Pacific Price To Sales Ratio vs Ev To Sales Analysis

PACB Stock  USD 2.27  0.07  2.99%   
Pacific Biosciences financial indicator trend analysis is much more than just breaking down Pacific Biosciences prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Pacific Biosciences is a good investment. Please check the relationship between Pacific Biosciences Price To Sales Ratio and its Ev To Sales accounts. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Pacific Biosciences of. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.

Price To Sales Ratio vs Ev To Sales

Price To Sales Ratio vs Ev To Sales Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Pacific Biosciences Price To Sales Ratio account and Ev To Sales. At this time, the significance of the direction appears to have strong contrarian relationship.
The correlation between Pacific Biosciences' Price To Sales Ratio and Ev To Sales is -0.69. Overlapping area represents the amount of variation of Price To Sales Ratio that can explain the historical movement of Ev To Sales in the same time period over historical financial statements of Pacific Biosciences of, assuming nothing else is changed. The correlation between historical values of Pacific Biosciences' Price To Sales Ratio and Ev To Sales is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Price To Sales Ratio of Pacific Biosciences of are associated (or correlated) with its Ev To Sales. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Ev To Sales has no effect on the direction of Price To Sales Ratio i.e., Pacific Biosciences' Price To Sales Ratio and Ev To Sales go up and down completely randomly.

Correlation Coefficient

-0.69
Relationship DirectionNegative 
Relationship StrengthWeak

Price To Sales Ratio

Price to Sales Ratio is figured by comparing Pacific Biosciences stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on Pacific Biosciences sales, a figure that is much harder to manipulate than other Pacific Biosciences of multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period.

Ev To Sales

The Enterprise Value to Sales ratio, a valuation metric used to compare the value of a company, including debt and excluding cash, to its sales revenue.
Most indicators from Pacific Biosciences' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Pacific Biosciences current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Pacific Biosciences of. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.
The current year's Selling General Administrative is expected to grow to about 177.3 M, whereas Tax Provision is forecasted to decline to (11.2 M).
 2021 2022 2023 2024 (projected)
Gross Profit58.9M49.0M52.8M28.1M
Total Revenue130.5M128.3M200.5M210.5M

Pacific Biosciences fundamental ratios Correlations

0.870.870.60.910.890.220.820.590.82-0.970.750.630.880.120.150.790.860.820.910.970.830.950.830.540.93
0.870.990.710.960.970.450.730.770.93-0.820.710.750.990.09-0.090.970.980.990.890.890.990.860.980.340.95
0.870.990.730.960.940.390.710.750.96-0.840.740.691.00.13-0.140.940.960.990.90.890.990.870.960.380.95
0.60.710.730.640.620.040.590.690.68-0.590.520.590.710.340.150.690.680.750.580.590.750.50.70.440.65
0.910.960.960.640.960.340.670.70.93-0.90.740.640.970.16-0.040.90.940.920.930.950.930.90.920.410.94
0.890.970.940.620.960.460.730.720.86-0.840.680.760.950.050.00.950.980.910.890.910.920.870.960.290.93
0.220.450.390.040.340.460.390.640.24-0.120.240.640.35-0.2-0.160.60.520.430.080.250.430.130.570.020.3
0.820.730.710.590.670.730.390.660.59-0.760.770.770.70.010.220.740.730.710.620.750.710.710.750.610.77
0.590.770.750.690.70.720.640.660.62-0.560.580.810.710.260.090.840.780.780.460.640.770.430.830.390.62
0.820.930.960.680.930.860.240.590.62-0.830.740.470.970.16-0.310.830.860.940.90.860.940.870.850.350.93
-0.97-0.82-0.84-0.59-0.9-0.84-0.12-0.76-0.56-0.83-0.8-0.5-0.86-0.22-0.1-0.72-0.79-0.77-0.89-0.96-0.78-0.93-0.75-0.55-0.91
0.750.710.740.520.740.680.240.770.580.74-0.80.440.730.34-0.070.630.640.70.640.780.710.710.660.650.79
0.630.750.690.590.640.760.640.770.810.47-0.50.440.66-0.010.350.870.820.720.50.60.720.50.850.280.61
0.880.991.00.710.970.950.350.70.710.97-0.860.730.660.12-0.150.920.950.980.920.90.980.90.940.360.96
0.120.090.130.340.160.05-0.20.010.260.16-0.220.34-0.010.120.370.030.040.110.010.20.120.00.060.360.1
0.15-0.09-0.140.15-0.040.0-0.160.220.09-0.31-0.1-0.070.35-0.150.37-0.020.01-0.15-0.080.08-0.14-0.06-0.020.29-0.12
0.790.970.940.690.90.950.60.740.840.83-0.720.630.870.920.03-0.020.990.950.770.810.950.741.00.30.87
0.860.980.960.680.940.980.520.730.780.86-0.790.640.820.950.040.010.990.950.850.870.950.820.990.290.91
0.820.990.990.750.920.910.430.710.780.94-0.770.70.720.980.11-0.150.950.950.850.841.00.810.960.360.92
0.910.890.90.580.930.890.080.620.460.9-0.890.640.50.920.01-0.080.770.850.850.90.860.970.810.30.92
0.970.890.890.590.950.910.250.750.640.86-0.960.780.60.90.20.080.810.870.840.90.850.930.840.50.93
0.830.990.990.750.930.920.430.710.770.94-0.780.710.720.980.12-0.140.950.951.00.860.850.820.960.370.93
0.950.860.870.50.90.870.130.710.430.87-0.930.710.50.90.0-0.060.740.820.810.970.930.820.780.390.94
0.830.980.960.70.920.960.570.750.830.85-0.750.660.850.940.06-0.021.00.990.960.810.840.960.780.320.89
0.540.340.380.440.410.290.020.610.390.35-0.550.650.280.360.360.290.30.290.360.30.50.370.390.320.39
0.930.950.950.650.940.930.30.770.620.93-0.910.790.610.960.1-0.120.870.910.920.920.930.930.940.890.39
Click cells to compare fundamentals

Pacific Biosciences Account Relationship Matchups

Pacific Biosciences fundamental ratios Accounts

201920202021202220232024 (projected)
Common Stock Shares Outstanding152.5M175.0M204.1M224.6M253.6M266.3M
Total Assets148.0M414.0M2.0B1.8B1.7B1.8B
Short Long Term Debt Total61.7M42.0M953.7M957.4M933.9M980.6M
Other Current Liab(13.9M)17.5M40.4M201.2M53.5M56.2M
Total Current Liabilities21.8M36.5M83.3M76.9M95.0M99.8M
Total Stockholder Equity54.9M335.5M791.0M562.9M701.3M736.4M
Other Liab2.0M10.3M215.0M2.6M3.0M2.8M
Property Plant And Equipment Net62.9M54.9M79.1M81.3M69.0M35.5M
Current Deferred Revenue7.6M10.3M36.0M32.3M16.3M13.1M
Net Debt12.6M(276.8M)493.0M632.3M754.0M791.7M
Retained Earnings(1.1B)(1.0B)(1.2B)(1.5B)(1.8B)(1.7B)
Accounts Payable8.4M3.6M11.0M12.0M15.1M7.6M
Cash49.1M318.8M460.7M325.1M179.9M137.4M
Non Current Assets Total66.9M59.2M901.2M912.1M1.0B1.1B
Non Currrent Assets Other42K879K1.2M10.5M3.7M3.7M
Other Assets4.0M33.5M1.2M13.5M1.00.95
Cash And Short Term Investments49.1M318.8M1.0B772.3M631.4M663.0M
Short Term Investments19.5M237.2M583.7M447.2M451.5M474.1M
Liabilities And Stockholders Equity148.0M414.0M2.0B1.8B1.7B1.8B
Non Current Liabilities Total71.2M42.0M1.1B1.1B949.7M997.2M
Other Current Assets3.4M5.7M7.9M10.6M17.3M18.2M
Other Stockholder Equity1.1B1.4B2.0B2.1B2.5B2.7B
Total Liab93.1M78.5M1.2B1.2B1.0B1.1B
Property Plant And Equipment Gross62.9M54.9M79.1M81.3M143.8M151.0M
Total Current Assets81.0M354.8M1.1B855.0M742.0M779.1M
Short Term Debt19.7M8.7M9.3M19.6M10.1M8.2M
Property Plant Equipment30.1M24.9M79.1M81.3M93.5M98.2M
Long Term Debt14.7M15.9M896.1M896.7M892.2M936.9M
Net Receivables15.3M16.8M24.2M18.8M36.6M38.4M
Common Stock Total Equity150K153K192K221K198.9K189.0K
Inventory13.3M14.2M24.6M50.4M56.7M59.5M
Common Stock153K192K221K227K268K254.6K
Net Tangible Assets54.9M335.5M(30.0M)(257.3M)(231.6M)(220.0M)
Retained Earnings Total Equity(982.1M)(1.1B)(1.0B)(1.2B)(1.1B)(1.2B)
Capital Surpluse1.1B1.1B1.4B2.0B2.3B1.2B

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Pacific Biosciences offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Pacific Biosciences' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Pacific Biosciences Of Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Pacific Biosciences Of Stock:
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Pacific Biosciences of. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.
You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.
Is Life Sciences Tools & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Pacific Biosciences. If investors know Pacific will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Pacific Biosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.46)
Revenue Per Share
0.64
Quarterly Revenue Growth
(0.28)
Return On Assets
(0.11)
Return On Equity
(0.65)
The market value of Pacific Biosciences is measured differently than its book value, which is the value of Pacific that is recorded on the company's balance sheet. Investors also form their own opinion of Pacific Biosciences' value that differs from its market value or its book value, called intrinsic value, which is Pacific Biosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Pacific Biosciences' market value can be influenced by many factors that don't directly affect Pacific Biosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Pacific Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Pacific Biosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Pacific Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.